Sangamo Therapeutics
SGMO
#5702
Rank
$0.32 B
Marketcap
$1.70
Share price
-2.30%
Change (1 day)
-70.33%
Change (1 year)

P/E ratio for Sangamo Therapeutics (SGMO)

P/E ratio as of March 2023 (TTM): -1.36

According to Sangamo Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.36. At the end of 2021 the company had a P/E ratio of -6.05.

P/E ratio history for Sangamo Therapeutics from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-6.05-63.95%
2020-16.874.41%
2019-9.62-40.5%
2018-16.2-30.99%
2017-23.4683.51%
2016-2.99-81%
2015-15.7-59.64%
2014-39.031.97%
2013-29.6111.45%
2012-14.0249.42%
2011-4.00

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
22.2-1,734.57%๐Ÿ‡บ๐Ÿ‡ธ USA
19.6-1,539.68%๐Ÿ‡บ๐Ÿ‡ธ USA
12.9-1,046.71%๐Ÿ‡บ๐Ÿ‡ธ USA
8.41-718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
22.1-1,722.26%๐Ÿ‡บ๐Ÿ‡ธ USA
18.4-1,454.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-20.3 1,392.35%๐Ÿ‡บ๐Ÿ‡ธ USA
117-8,671.54%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.